Fundraising FoxFBB Biomed
Iowa City, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into FBB Biomed
Sign up to see every warm intro you have to FBB Biomed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FBB Biomed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FBB Biomed builds an analytics platform that uses blood RNA-seq data to quantify gene activity across the biological systems involved in a patient's chronic disease. It serves diagnostic labs offering RNA-based monitoring tests and biopharma companies stratifying trial participants and measuring individual treatment response.
Founders & leadership
FBB Biomed was founded in 2019 by Howard Urnovitz.
HU
Howard UrnovitzFounder · Chief Executive OfficerHoward Urnovitz spent his career in virology, molecular diagnostics, and immunology, with early work on non-coding DNA regions. He is founder of FBB Biomed, which develops an RNA-based analytics platform for diagnostic labs and biopharma companies to detect disease and measure treatment response from blood samples.
Investors · 1
Reported raises · per SEC filings
Form D private placements$511K disclosed across 4 of 5 rounds · 2019–2024
▶$326KraisedAug 2020 · 6 investors · BiotechnologyRule 506(b)
▶$326KraisedAug 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $326K
- Minimum investment
- $10K
- Proceeds to insiders
- $70K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$75KraisedMar 2020 · 4 investors · BiotechnologyRule 506(b)
▶$75KraisedMar 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $105K
- Amount sold
- $75K
- Minimum investment
- $10K
- Proceeds to insiders
- $20K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$77.5KraisedDec 2019 · 16 investors · BiotechnologyRule 506(b)
▶$77.5KraisedDec 2019 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $77.5K
- Amount sold
- $77.5K
- Minimum investment
- $150
- Proceeds to insiders
- $10K
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$32.5KraisedDec 2019 · 3 investors · BiotechnologyRule 506(b)
▶$32.5KraisedDec 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $32.5K
- Amount sold
- $32.5K
- Minimum investment
- $2K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does FBB Biomed do?
- FBB Biomed builds an analytics platform that uses blood RNA-seq data to quantify gene activity across the biological systems involved in a patient's chronic disease. It serves diagnostic labs offering RNA-based monitoring tests and biopharma companies stratifying trial participants and measuring individual treatment response.
- Who founded FBB Biomed?
- FBB Biomed was founded by Howard Urnovitz in 2019.
- Who are FBB Biomed's investors?
- FBB Biomed's investors include Loyal VC.
- How much funding has FBB Biomed raised?
- FBB Biomed has disclosed $511K raised across 4 of its 5 known rounds.
- Where is FBB Biomed headquartered?
- FBB Biomed is headquartered in Iowa City, US.